Latest filing published 05 Jul 2017 for Rein Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Scott Kapnick: trading record in brief
All filings by Scott Kapnick on record concern Rein Therapeutics, Inc. Activity is concentrated on a single trading day, 5 July 2017, with 4 filings.
On the market, this insider has only ever bought: 3 purchases, €3.9M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2018: 1 purchase and no sales on the market.
In size, the median ticket on the buying side is €881k.
On 14 August 2018 came the latest disclosure, an open-market purchase for €881k in Rein Therapeutics, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Scott Kapnick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 285,438 sharesCommon StockSEC:0000899243-17-017894:0
- 159,307 shares@ US$15.00Common StockSEC:0000899243-17-017894:1Canonical exit: 3 Oct 2017 (T+90)
- 66,666 shares@ US$15.00Common StockSEC:0000899243-17-017894:2Canonical exit: 3 Oct 2017 (T+90)
3 of 3 declarations
